medline inc - MDLN

MDLN

Close Chg Chg %
45.69 -0.09 -0.20%

Closed Market

45.60

-0.09 (0.20%)

Volume: 4.55M

Last Updated:

Apr 10, 2026, 4:00 PM EDT

Company Overview: medline inc - MDLN

MDLN Key Data

Open

$45.89

Day Range

45.40 - 46.31

52 Week Range

N/A - N/A

Market Cap

$37.08B

Shares Outstanding

811.65M

Public Float

450.03M

Beta

1.98

Rev. Per Employee

N/A

P/E Ratio

32.01

EPS

$1.45

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

7.06M

 

MDLN Performance

1 Week
 
2.98%
 
1 Month
 
9.99%
 
3 Months
 
12.54%
 
1 Year
 
N/A
 
5 Years
 
N/A
 

MDLN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 30
Full Ratings ➔

About medline inc - MDLN

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

MDLN At a Glance

Medline, Inc.
3 Lakes Drive
Northfield, Illinois 60093
Phone 1-847-949-5500 Revenue 28.43B
Industry Medical Specialties Net Income 1.16B
Sector Health Technology 2025 Sales Growth 11.467%
Fiscal Year-end 12 / 2026 Employees 45,000
View SEC Filings

MDLN Valuation

P/E Current 32.011
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 29.426
Price to Sales Ratio 1.199
Price to Book Ratio 3.176
Price to Cash Flow Ratio 19.56
Enterprise Value to EBITDA 16.541
Enterprise Value to Sales 1.89
Total Debt to Enterprise Value 0.242

MDLN Efficiency

Revenue/Employee 631,822.222
Income Per Employee 25,755.556
Receivables Turnover 8.048
Total Asset Turnover 0.764

MDLN Liquidity

Current Ratio 4.289
Quick Ratio 2.373
Cash Ratio 0.78

MDLN Profitability

Gross Margin 23.966
Operating Margin 7.868
Pretax Margin 4.389
Net Margin 4.076
Return on Assets 3.113
Return on Equity 8.503
Return on Total Capital 4.88
Return on Invested Capital 4.076

MDLN Capital Structure

Total Debt to Total Equity 121.198
Total Debt to Total Capital 54.792
Total Debt to Total Assets 33.814
Long-Term Debt to Equity 119.866
Long-Term Debt to Total Capital 54.189
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Medline Inc - MDLN

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
21.45B 23.23B 25.51B 28.43B
Sales Growth
- +8.31% +9.80% +11.47%
Cost of Goods Sold (COGS) incl D&A
16.89B 18.01B 19.22B 21.62B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
933.00M 951.00M 977.00M 1.01B
Depreciation
273.00M 289.00M 292.00M 307.00M
Amortization of Intangibles
660.00M 662.00M 685.00M 704.00M
COGS Growth
- +6.61% +6.71% +12.50%
Gross Income
4.56B 5.22B 6.29B 6.81B
Gross Income Growth
- +14.61% +20.45% +8.31%
Gross Profit Margin
+21.25% +22.48% +24.66% +23.97%
2022 2023 2024 2025 5-year trend
SG&A Expense
3.68B 3.87B 4.11B 4.50B
Research & Development
58.00M 60.00M 67.00M 80.00M
Other SG&A
3.62B 3.81B 4.04B 4.42B
SGA Growth
- +5.20% +6.23% +9.52%
Other Operating Expense
11.00M (88.00M) (42.00M) 78.00M
Unusual Expense
(9.00M) 161.00M 83.00M 92.00M
EBIT after Unusual Expense
879.00M 1.28B 2.14B 2.15B
Non Operating Income/Expense
42.00M 356.00M 413.00M 131.00M
Non-Operating Interest Income
27.00M 237.00M 280.00M 133.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
911.00M 1.38B 1.31B 1.03B
Interest Expense Growth
- +50.93% -4.80% -21.47%
Gross Interest Expense
911.00M 1.38B 1.31B 1.03B
Interest Capitalized
- - - -
-
Pretax Income
10.00M 264.00M 1.25B 1.25B
Pretax Income Growth
- +2,540.00% +371.97% +0.16%
Pretax Margin
+0.05% +1.14% +4.88% +4.39%
Income Tax
35.00M 30.00M 46.00M 91.00M
Income Tax - Current - Domestic
25.00M 7.00M 12.00M 28.00M
Income Tax - Current - Foreign
24.00M 46.00M 58.00M 83.00M
Income Tax - Deferred - Domestic
- - 2.00M 4.00M
-
Income Tax - Deferred - Foreign
(16.00M) (23.00M) (24.00M) (24.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(25.00M) 234.00M 1.20B 1.16B
Minority Interest Expense
- - - (2.00M)
-
Net Income
(25.00M) 234.00M 1.20B 1.16B
Net Income Growth
- +1,036.00% +412.82% -3.42%
Net Margin Growth
-0.12% +1.01% +4.70% +4.08%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(25.00M) 234.00M 1.20B 1.16B
Preferred Dividends
- - - -
-
Net Income Available to Common
(25.00M) 234.00M 1.20B 1.16B
EPS (Basic)
-0.0313 0.2926 1.5004 1.4273
EPS (Basic) Growth
- +1,034.82% +412.78% -4.87%
Basic Shares Outstanding
799.80M 799.80M 799.80M 812.00M
EPS (Diluted)
-0.0313 0.2926 1.5004 1.4273
EPS (Diluted) Growth
- +1,034.82% +412.78% -4.87%
Diluted Shares Outstanding
799.80M 799.80M 799.80M 812.00M
EBITDA
1.80B 2.40B 3.20B 3.25B
EBITDA Growth
- +32.83% +33.70% +1.44%
EBITDA Margin
+8.41% +10.31% +12.55% +11.42%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 53.593
Number of Ratings 30 Current Quarters Estimate 0.331
FY Report Date 06 / 2026 Current Year's Estimate 1.465
Last Quarter’s Earnings 0.29 Median PE on CY Estimate N/A
Year Ago Earnings 1.431 Next Fiscal Year Estimate 1.643
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 25 25 26 26
Mean Estimate 0.33 0.37 1.46 1.64
High Estimates 0.42 0.41 1.57 1.83
Low Estimate 0.30 0.34 1.38 1.45
Coefficient of Variance 7.99 4.41 3.34 4.75

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 20 20 18
OVERWEIGHT 4 4 3
HOLD 6 5 5
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Buy Overweight

Medline Inc in the News